<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02627209</url>
  </required_header>
  <id_info>
    <org_study_id>DGH-070</org_study_id>
    <nct_id>NCT02627209</nct_id>
  </id_info>
  <brief_title>The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis</brief_title>
  <acronym>uveitis</acronym>
  <official_title>Non-infectious and Infectious Uveitis Diagnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ozlem Sahin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dünyagöz Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the significance of differences in serum angiotensin converting enzyme
      and lysozyme levels of patients with ocular involvement of other autoimmune inflammatory and
      infectious diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Increased serum levels of angiotensin converting enzyme and lysozyme are considered as
      inflammatory markers for diagnosis of sarcoidosis which is an autoimmune inflammatory
      disease. Sarcoidosis, ankylosing spondylitis and Behcet's disease are the most common
      autoimmune inflammatory diseases involving the eye.

      Elevated serum angiotensin converting enzyme levels have also been reported in tuberculosis.
      Syphilis and tuberculosis are the most common infectious diseases involving the eye.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of serum angiotensin converting enzyme level</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of serum lysozyme level</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Sarcoidosis</condition>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>serum angiotensin converting enzyme</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>spectrophotometric assay</description>
  </arm_group>
  <arm_group>
    <arm_group_label>serum lysozyme</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>radial immunodiffusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>spectrophotometric assay</intervention_name>
    <description>measurement of enzyme activity in the serum</description>
    <arm_group_label>serum angiotensin converting enzyme</arm_group_label>
    <arm_group_label>serum lysozyme</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>radial immunodiffusion</intervention_name>
    <description>measurement of the precipitated ring diameters showing enzyme activity in the serum</description>
    <arm_group_label>serum angiotensin converting enzyme</arm_group_label>
    <arm_group_label>serum lysozyme</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects have ocular inflammation diagnosed as sarcoidosis, ankylosing spondylitis,
             behcet's disease

          -  Subjects have ocular infection diagnosed as tuberculosis and syphilis

          -  Subjects have refractive errors only

        Exclusion Criteria:

          -  Subjects using ACE inhibitors, systemic steroids, immunosuppressive or
             immunomodulatory therapies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>86 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ioannis Pallikaris, MD</last_name>
    <role>Study Chair</role>
    <affiliation>DunyaGoz Hospital, Etiler, yanarsu sokak no.1 besiktaş Istanbul Turkey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ozlem sahin, MD</last_name>
    <phone>90-537-5523064</phone>
    <email>ozlem1158@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eda Karaismailoglu, MS</last_name>
    <phone>90-533-3097848</phone>
    <email>edaozturk@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>DunyaGoz hospital Tunus caddesi no.28 kavaklidere</name>
      <address>
        <city>Cankaya</city>
        <state>Ankara</state>
        <zip>06450</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ozlem sahin, MD</last_name>
      <phone>90-537-5523064</phone>
      <email>ozlem1158@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>eda karaismailoğlu, MS</last_name>
      <phone>90-533-3097848</phone>
      <email>edaozturk@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Birnbaum AD, Oh FS, Chakrabarti A, Tessler HH, Goldstein DA. Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch Ophthalmol. 2011 Apr;129(4):409-13. doi: 10.1001/archophthalmol.2011.52.</citation>
    <PMID>21482866</PMID>
  </results_reference>
  <results_reference>
    <citation>Sen DK, Sarin GS. Immunoassay of serum muramidase (lysozyme) in ocular diseases. Indian J Ophthalmol. 1987;35(5-6):103-7.</citation>
    <PMID>3508756</PMID>
  </results_reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2015</study_first_posted>
  <last_update_submitted>December 9, 2015</last_update_submitted>
  <last_update_submitted_qc>December 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Dünyagöz Hospital</investigator_affiliation>
    <investigator_full_name>Ozlem Sahin</investigator_full_name>
    <investigator_title>Medical Doctor, Specialist in Ophthalmology, Uveitis and Ocular Immunology</investigator_title>
  </responsible_party>
  <keyword>Angiotensin converting enzyme</keyword>
  <keyword>Lysozyme</keyword>
  <keyword>Ankylosing spondylitis</keyword>
  <keyword>Behcet's disease</keyword>
  <keyword>Sarcoidosis</keyword>
  <keyword>Syphilis</keyword>
  <keyword>Tuberculosis</keyword>
  <keyword>Ocular inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Sarcoidosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muramidase</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

